Theresia M Westers

Theresia M Westers

UNVERIFIED PROFILE

Are you Theresia M Westers?   Register this Author

Register author
Theresia M Westers

Theresia M Westers

Publications by authors named "Theresia M Westers"

Are you Theresia M Westers?   Register this Author

68Publications

1637Reads

19Profile Views

The non-erythroid myeloblast count rule in myelodysplastic syndromes: fruitful or futile?

Haematologica 2019 Apr 19. Epub 2019 Apr 19.

Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, The Netherlands;

View Article

Download full-text PDF

Source
http://www.haematologica.org/lookup/doi/10.3324/haematol.201
Publisher Site
http://dx.doi.org/10.3324/haematol.2018.212563DOI Listing
April 2019

Validation of and proposals for refinements of the WHO 2016 classification for myelodysplastic syndromes.

Am J Hematol 2017 Nov 24;92(11):E631-E634. Epub 2017 Aug 24.

Department of Haematology, VU University Medical Center, Cancer Center Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajh.24867DOI Listing
November 2017

Transcriptional profiling reveals functional dichotomy between human slan non-classical monocytes and myeloid dendritic cells.

J Leukoc Biol 2017 10 18;102(4):1055-1068. Epub 2017 Jul 18.

Department of Hematology, Cancer Center Amsterdam, Vrije Universiteit Amsterdam University Medical Center, Amsterdam, The Netherlands;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.3MA0117-037RDOI Listing
October 2017

Application of flow cytometry for myelodysplastic syndromes: Pitfalls and technical considerations.

Cytometry B Clin Cytom 2016 07 14;90(4):358-67. Epub 2015 Dec 14.

Department of Hematology, Cancer Center Amsterdam (CCA), VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21333DOI Listing
July 2016

Prognostic relevance of morphological classification models for myelodysplastic syndromes in an era of the revised International Prognostic Scoring System.

Eur J Cancer 2016 Mar 19;56:10-20. Epub 2016 Jan 19.

Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.12.004DOI Listing
March 2016

Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.

Eur J Cancer 2016 Feb 22;54:49-56. Epub 2015 Dec 22.

Department of Hematology, VU University Medical Center, Cancer Center Amsterdam (VUmc CCA), De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2015.11.013DOI Listing
February 2016

Differential capacity of human interleukin-4 and interferon-α monocyte-derived dendritic cells for cross-presentation of free versus cell-associated antigen.

Cancer Immunol Immunother 2015 Nov 28;64(11):1419-27. Epub 2015 Jul 28.

Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081HV, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-015-1741-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4612333PMC
November 2015

Immunophenotyping for diagnosis and prognosis in MDS: ready for general application?

Best Pract Res Clin Haematol 2015 Mar 11;28(1):14-21. Epub 2014 Nov 11.

Department of Hematology, VU University Medical Center, Cancer Center Amsterdam (VUmc CCA), Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2014.11.003DOI Listing
March 2015

High flow cytometric scores identify adverse prognostic subgroups within the revised international prognostic scoring system for myelodysplastic syndromes.

Br J Haematol 2014 Oct 30;167(1):100-9. Epub 2014 Jun 30.

Department of Haematology, Cancer Centre Amsterdam, VU University Medical Centre, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12994DOI Listing
October 2014

ZAP70 in B-CLL cells related to the expression in NK cells is a surrogate marker for mutational status.

Cytometry B Clin Cytom 2014 Jul 8;86(4):280-7. Epub 2013 Oct 8.

Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21132DOI Listing
July 2014

loading of skin dendritic cells with apoptotic bleb-derived antigens for the induction of tumor-directed immunity.

Oncoimmunology 2014;3(7):e946360. Epub 2014 Jul 3.

Department of Medical Oncology; VU University Medical Center; Cancer Center Amsterdam ; Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/21624011.2014.946360DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292219PMC
July 2014

Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes.

Cytometry B Clin Cytom 2014 May 28;86(3):207-15. Epub 2014 Jan 28.

Department of Hematology, VU Institute of Cancer and Immunology (V-ICI), Cancer Center Amsterdam (CCA), VU University Medical Center, Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21160DOI Listing
May 2014

Apoptotic blebs from leukemic cells as a preferred source of tumor-associated antigen for dendritic cell-based vaccines.

Cancer Immunol Immunother 2014 Apr 3;63(4):335-45. Epub 2014 Jan 3.

Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-013-1515-6DOI Listing
April 2014

Absence of aberrant myeloid progenitors by flow cytometry is associated with favorable response to azacitidine in higher risk myelodysplastic syndromes.

Cytometry B Clin Cytom 2014 Jan 15. Epub 2014 Jan 15.

Department of Hematology, VU Institute of Cancer and Immunology (V-ICI), Cancer Center Amsterdam (CCA), VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cytob.21160DOI Listing
January 2014

ZAP70 in B-CLL cells related to the expression in NK cells is a surrogate marker for mutational status.

Cytometry B Clin Cytom 2013 Oct 1. Epub 2013 Oct 1.

Department of Hematology, VU University medical center, Cancer Center Amsterdam, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cytob.21132DOI Listing
October 2013

Targeting the acute myeloid leukemic stem cell compartment by enhancing tumor cell-based vaccines.

Immunotherapy 2013 Aug;5(8):859-68

Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.13.76DOI Listing
August 2013

Cutting edge: flow cytometry in myelodysplastic syndromes.

J Natl Compr Canc Netw 2013 Jul;11(7):892-902

Department of Hematology, Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2013.0106DOI Listing
July 2013

Dendritic cells in myelodysplastic syndromes: from pathogenesis to immunotherapy.

Immunotherapy 2013 Jun;5(6):621-37

Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.13.51DOI Listing
June 2013

MicroRNA profiling can classify acute leukemias of ambiguous lineage as either acute myeloid leukemia or acute lymphoid leukemia.

Clin Cancer Res 2013 Apr 26;19(8):2187-96. Epub 2013 Feb 26.

Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3657DOI Listing
April 2013

A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin.

Cytometry B Clin Cytom 2013 Mar 16;84(2):114-8. Epub 2013 Jan 16.

Department of Hematology, Cancer Centre Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.21072DOI Listing
March 2013

Azacitidine differentially affects CD4(pos) T-cell polarization in vitro and in vivo in high risk myelodysplastic syndromes.

Leuk Res 2012 Jul 14;36(7):921-30. Epub 2012 Apr 14.

Department of Hematology, VU University Medical Center, Cancer Center Amsterdam, De Boelelaan 1117, 1081HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2012.03.026DOI Listing
July 2012

Class II-associated invariant chain peptide expression represents a novel parameter for flow cytometric detection of acute promyelocytic leukemia.

Am J Pathol 2011 Nov 9;179(5):2157-61. Epub 2011 Sep 9.

Department of Hematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S000294401100748
Publisher Site
http://dx.doi.org/10.1016/j.ajpath.2011.07.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204089PMC
November 2011

Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy.

Br J Haematol 2011 Jun 13;153(5):568-81. Epub 2011 Apr 13.

Department of Haematology, VU Institute for Cancer and Immunology, VU University Medical Centre, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2011.08683.xDOI Listing
June 2011

Absence of class II-associated invariant chain peptide on leukemic blasts of patients promotes activation of autologous leukemia-reactive CD4+ T cells.

Cancer Res 2011 Apr 10;71(7):2507-17. Epub 2011 Feb 10.

Department of Hematology, Cancer Center Amsterdam and VU Institute for Cancer and Immunology, VU University Medical Center, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-3689DOI Listing
April 2011

Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells.

Immunotherapy 2011 Apr;3(4):569-76

Department of Hematology, Cancer Center Amsterdam/VUmc Institute for Cancer & Immunology, VU University Medical Center, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/imt.11.3
Publisher Site
http://dx.doi.org/10.2217/imt.11.3DOI Listing
April 2011

Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation.

Cancer Immunol Immunother 2011 Jan 22;60(1):37-47. Epub 2010 Sep 22.

Department of Hematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-010-0917-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3029806PMC
January 2011

Class II-associated invariant chain peptide down-modulation enhances the immunogenicity of myeloid leukemic blasts resulting in increased CD4+ T-cell responses.

Haematologica 2010 Mar 10;95(3):485-93. Epub 2009 Nov 10.

Department of Hematology, VU Institute for Cancer and Immunology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2009.010595DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833080PMC
March 2010

Recent advances in antigen-loaded dendritic cell-based strategies for treatment of minimal residual disease in acute myeloid leukemia.

Immunotherapy 2010 Jan;2(1):69-83

Department of Hematology, VU Institute for Cancer & Immunology, Cancer Center Amsterdam, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.09.85DOI Listing
January 2010

Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.

Blood 2008 Feb 30;111(3):1067-77. Epub 2007 Oct 30.

Department of Hematology, Vrije Universiteit (VU) University Medical Center, VU-Institute for Cancer and Immunology, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/content/111/3/1067.full.pdf
Web Search
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2007-07-09
Publisher Site
http://dx.doi.org/10.1182/blood-2007-07-098764DOI Listing
February 2008

Dendritic cell-based immunotherapy in acute and chronic myeloid leukaemia.

Biomed Pharmacother 2007 Jul 27;61(6):306-14. Epub 2007 Feb 27.

Department of Haematology, VU University Medical Centre, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.biopha.2007.01.005DOI Listing
July 2007

Leukemia-specific T-cell reactivity induced by leukemic dendritic cells is augmented by 4-1BB targeting.

Clin Cancer Res 2007 Jan 14;13(1):307-15. Epub 2006 Dec 14.

Department of Hematology, VU University Medical Center, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1430DOI Listing
January 2007

Principles of dendritic cell-based immunotherapy in myeloid leukemia.

Immunobiology 2006 21;211(6-8):663-76. Epub 2006 Jul 21.

Department of Hematology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imbio.2006.06.003DOI Listing
December 2006

Feasibility of clinical dendritic cell vaccination in acute myeloid leukemia.

Immunobiology 2006 13;211(6-8):677-85. Epub 2006 Jul 13.

Department of Hematology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.imbio.2006.05.013DOI Listing
December 2006

Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemia.

Haematologica 2006 Mar;91(3):348-55

Department of Hematology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
March 2006

Employing the immunological synapse in AML: development of leukemic dendritic cells for active specific immunization.

Immunobiology 2005 ;210(2-4):249-57

Department of Hematology, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S017129850500092
Publisher Site
http://dx.doi.org/10.1016/j.imbio.2005.05.019DOI Listing
October 2005

Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation.

Cancer Immunol Immunother 2003 Jul 11;52(7):455-62. Epub 2003 Apr 11.

Department of Haematology BR 250, VU University Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-003-0389-4DOI Listing
July 2003

Rapid generation of antigen-presenting cells from leukaemic blasts in acute myeloid leukaemia.

Cancer Immunol Immunother 2003 Jan 7;52(1):17-27. Epub 2002 Dec 7.

Department of Haematology, VU University Medical Centre, De Boelelaan 1117, Amsterdam, 1081 HV, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-002-0316-0DOI Listing
January 2003